Outsourcing of R&D Through Acquisitions in the Pharmaceutical Industry
The report examines the performance of acquirers of 160 biotechnology firms and finds evidence that generally, the acquirers realize significant positive returns, which is positively correlated with the acquirers access to information about the research and development activities.
Link
http://mgt.gatech.edu/tiger/files/higgins_dec03.pdf